Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 48 studies | 55% ± 18% | |
classical monocyte | 26 studies | 61% ± 13% | |
conventional dendritic cell | 26 studies | 53% ± 18% | |
mast cell | 25 studies | 45% ± 12% | |
monocyte | 23 studies | 51% ± 14% | |
non-classical monocyte | 23 studies | 58% ± 13% | |
endothelial cell | 23 studies | 30% ± 14% | |
plasmacytoid dendritic cell | 21 studies | 54% ± 15% | |
dendritic cell | 18 studies | 51% ± 18% | |
astrocyte | 18 studies | 40% ± 19% | |
myeloid cell | 17 studies | 57% ± 16% | |
oligodendrocyte | 16 studies | 64% ± 17% | |
microglial cell | 16 studies | 53% ± 16% | |
fibroblast | 16 studies | 23% ± 7% | |
ciliated cell | 15 studies | 35% ± 13% | |
oligodendrocyte precursor cell | 14 studies | 54% ± 19% | |
glutamatergic neuron | 12 studies | 54% ± 21% | |
GABAergic neuron | 11 studies | 54% ± 20% | |
epithelial cell | 10 studies | 31% ± 10% | |
pericyte | 10 studies | 26% ± 14% | |
endothelial cell of lymphatic vessel | 10 studies | 22% ± 6% | |
neutrophil | 9 studies | 33% ± 10% | |
adipocyte | 9 studies | 34% ± 9% | |
alveolar macrophage | 8 studies | 54% ± 11% | |
neuron | 8 studies | 46% ± 23% | |
hematopoietic stem cell | 8 studies | 43% ± 13% | |
mononuclear phagocyte | 7 studies | 54% ± 15% | |
leukocyte | 7 studies | 36% ± 16% | |
smooth muscle cell | 7 studies | 19% ± 2% | |
hematopoietic precursor cell | 6 studies | 45% ± 14% | |
basal cell | 6 studies | 26% ± 9% | |
club cell | 6 studies | 24% ± 7% | |
interneuron | 6 studies | 66% ± 10% | |
retinal ganglion cell | 6 studies | 34% ± 15% | |
respiratory goblet cell | 5 studies | 36% ± 16% | |
glial cell | 5 studies | 45% ± 12% | |
retinal cone cell | 5 studies | 44% ± 16% | |
mucus secreting cell | 5 studies | 36% ± 12% | |
abnormal cell | 5 studies | 24% ± 9% | |
intermediate monocyte | 5 studies | 66% ± 11% | |
duct epithelial cell | 4 studies | 30% ± 22% | |
CD16-negative, CD56-bright natural killer cell, human | 4 studies | 20% ± 3% | |
granule cell | 4 studies | 57% ± 9% | |
progenitor cell | 4 studies | 46% ± 20% | |
innate lymphoid cell | 4 studies | 23% ± 11% | |
retinal pigment epithelial cell | 4 studies | 48% ± 8% | |
Mueller cell | 4 studies | 34% ± 21% | |
retina horizontal cell | 4 studies | 26% ± 9% | |
retinal rod cell | 4 studies | 36% ± 5% | |
endothelial cell of vascular tree | 4 studies | 23% ± 7% | |
myofibroblast cell | 4 studies | 22% ± 8% | |
hepatocyte | 4 studies | 42% ± 18% | |
megakaryocyte-erythroid progenitor cell | 4 studies | 70% ± 28% | |
secretory cell | 3 studies | 26% ± 4% | |
type B pancreatic cell | 3 studies | 47% ± 19% | |
monocyte-derived dendritic cell | 3 studies | 50% ± 25% | |
GABAergic interneuron | 3 studies | 56% ± 11% | |
common myeloid progenitor | 3 studies | 40% ± 25% | |
erythroblast | 3 studies | 44% ± 24% | |
lymphocyte | 3 studies | 25% ± 4% | |
megakaryocyte | 3 studies | 36% ± 15% | |
capillary endothelial cell | 3 studies | 18% ± 2% | |
serous secreting cell | 3 studies | 33% ± 11% | |
cardiac muscle cell | 3 studies | 17% ± 2% | |
tissue-resident macrophage | 3 studies | 59% ± 2% | |
GABAergic amacrine cell | 3 studies | 29% ± 6% | |
amacrine cell | 3 studies | 33% ± 4% | |
glycinergic amacrine cell | 3 studies | 35% ± 5% | |
inflammatory macrophage | 3 studies | 43% ± 5% | |
type I pneumocyte | 3 studies | 21% ± 4% | |
neural progenitor cell | 3 studies | 47% ± 21% | |
ependymal cell | 3 studies | 47% ± 16% | |
connective tissue cell | 3 studies | 35% ± 14% | |
granulocyte | 3 studies | 48% ± 5% | |
intestinal crypt stem cell | 3 studies | 25% ± 6% | |
Schwann cell | 3 studies | 29% ± 12% | |
melanocyte | 3 studies | 27% ± 7% | |
goblet cell | 3 studies | 36% ± 26% | |
transit amplifying cell | 3 studies | 26% ± 8% | |
natural killer cell | 3 studies | 32% ± 7% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 20 studies | 51% ± 20% | |
peripheral blood | 16 studies | 24% ± 7% | |
lung | 15 studies | 25% ± 8% | |
eye | 5 studies | 39% ± 10% | |
adipose | 5 studies | 25% ± 5% | |
liver | 5 studies | 27% ± 9% | |
intestine | 4 studies | 21% ± 5% | |
kidney | 4 studies | 22% ± 1% | |
bone marrow | 4 studies | 26% ± 7% | |
pancreas | 3 studies | 32% ± 13% | |
heart | 3 studies | 21% ± 2% | |
uterus | 3 studies | 25% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 5744.78 | 226 / 226 | 100% | 19.97 | 406 / 406 |
brain | 100% | 7952.68 | 2641 / 2642 | 100% | 31.46 | 705 / 705 |
breast | 100% | 6432.55 | 459 / 459 | 100% | 19.75 | 1117 / 1118 |
kidney | 100% | 3787.13 | 89 / 89 | 100% | 21.79 | 900 / 901 |
ovary | 100% | 4842.20 | 180 / 180 | 100% | 17.77 | 429 / 430 |
lung | 100% | 5794.53 | 578 / 578 | 100% | 15.61 | 1151 / 1155 |
prostate | 100% | 4303.75 | 244 / 245 | 100% | 16.76 | 502 / 502 |
thymus | 100% | 3854.96 | 651 / 653 | 100% | 15.14 | 604 / 605 |
uterus | 100% | 5129.19 | 170 / 170 | 99% | 14.80 | 454 / 459 |
intestine | 100% | 5029.97 | 966 / 966 | 99% | 13.50 | 521 / 527 |
adrenal gland | 100% | 3945.17 | 258 / 258 | 99% | 13.29 | 227 / 230 |
pancreas | 99% | 3226.66 | 325 / 328 | 99% | 15.84 | 177 / 178 |
stomach | 100% | 4227.90 | 359 / 359 | 98% | 12.98 | 279 / 286 |
skin | 96% | 2319.97 | 1745 / 1809 | 100% | 19.32 | 471 / 472 |
bladder | 100% | 4572.71 | 21 / 21 | 91% | 10.83 | 461 / 504 |
esophagus | 95% | 4156.82 | 1378 / 1445 | 92% | 9.92 | 168 / 183 |
adipose | 100% | 7839.41 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 17.59 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 15.48 | 29 / 29 |
spleen | 100% | 4789.94 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 6303.97 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 2778.41 | 792 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 14.83 | 44 / 45 |
heart | 97% | 2759.48 | 831 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 82% | 10796.40 | 763 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006915 | Biological process | apoptotic process |
GO_0016567 | Biological process | protein ubiquitination |
GO_0006511 | Biological process | ubiquitin-dependent protein catabolic process |
GO_0012501 | Biological process | programmed cell death |
GO_0016020 | Cellular component | membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
GO_0046872 | Molecular function | metal ion binding |
Gene name | RNF130 |
Protein name | E3 ubiquitin-protein ligase RNF130 (EC 2.3.2.27) (Goliath homolog) (H-Goliath) (RING finger protein 130) (RING-type E3 ubiquitin transferase RNF130) RNF130 protein (cDNA, FLJ93572, Homo sapiens goliath protein (GP), mRNA) Ring finger protein 130 RNF130 protein |
Synonyms | |
Description | FUNCTION: May have a role during the programmed cell death of hematopoietic cells (By similarity). Acts as an E3 ubiquitin-protein ligase. . |
Accessions | E5RI87 Q86XS8 ENST00000261947.4 [Q86XS8-2] ENST00000522208.6 Q1WWL6 ENST00000520911.5 ENST00000521389.6 [Q86XS8-1] A0A0C4DGE2 Q2HIY3 |